NINGBO INNO PHARMCHEM CO.,LTD. is a trusted supplier of high-quality chemical compounds, including Phenylacetylglutamine (CAS 28047-15-6), which plays a significant role in pharmaceutical research and development.

Phenylacetylglutamine is a naturally occurring human metabolite with a unique chemical structure. Its primary importance lies in its role in nitrogen waste removal, acting as an alternative route for excretion when the urea cycle is compromised. This makes it a key compound in the study and treatment of urea cycle disorders. The study of phenylacetylglutamine urea cycle support mechanisms is vital for developing effective therapies.

The compound is also recognized for its utility as a phenylacetylglutamine pharmaceutical intermediate. Its structure allows for further modification and synthesis, making it a valuable building block in the development of new pharmaceutical agents. Researchers are exploring its potential in various therapeutic areas, leveraging its biological activity.

Furthermore, Phenylacetylglutamine serves as an important biomarker for metabolic age. The concentration of this metabolite in urine can provide an indication of an individual's biological age, reflecting changes in metabolic processes and gut microbiota activity over time. Understanding these correlations can lead to advancements in aging research and the development of interventions for age-related diseases.

Additionally, Phenylacetylglutamine is being investigated for its role in kidney health and cardiovascular conditions. Its presence as a phenylacetylglutamine kidney disease indicator and its association with cardiovascular health highlight its broad biological significance. The compound’s role in phenylacetylglutamine metabolite excretion is fundamental to these studies.

NINGBO INNO PHARMCHEM CO.,LTD. is committed to supporting pharmaceutical research by providing reliable and high-purity Phenylacetylglutamine. Our contribution enables scientists to delve deeper into its applications, from understanding metabolic pathways to developing novel treatments, thereby advancing the frontiers of medical science.